Hematologic Malignancies

John M. Burke MD Elias Jabbour MD Rami S. Komrokji MD and Shaji Kumar MD review and share their expert perspectives on key hematologic malignancy findings presented at the 2017 American Society of Clinical Oncology Annual Meeting.

Share

Supporters

AbbVie

Amgen, Inc.

AstraZeneca

Celgene

Genentech Roche Virology

Halozyme

Incyte

Merck Oncology